Ex-OpenAI exec Kevin Weil co-founds AI drug discovery startup Warp with $215M Series A
syhw · x · 2026-10-23
Warp Sciences has launched: a new company applying AI and robotics to accelerate drug discovery, having raised a $215M Series A led by Lightspeed.
- Founding team: former OpenAI product head Kevin Weil, former US Chief Data Scientist DJ Patil, Meta FAIR co-founder Manohar Paluri (who announced joining via this retweet), and drug hunter Sol Reisberg.
- Early team includes Brett Spears, who helped achieve Q>1 fusion at LLNL.
- Model: a US-based chemistry CRO combining expert chemists, AI, and robotically automated labs to shorten the make-test-learn loop of drug discovery, with experiment data feeding back into better models and labs—rebuilding chemistry capacity that has moved overseas.
- Angel investors include Brian Armstrong, Reid Hoffman, Dylan Field, Mark Chen, Sébastien Bubeck, Mike Krieger, Sarah Friar and other OpenAI/Anthropic/tech figures.
More from Companies & People
- eMudhra exits SSL business amid botched CA key generation and looming Chrome distrust — saibharadwaj · 2026-10-23
- Every app company claims to be 'a database for agents' — until you look at database pricing — matt_slotnick · 2026-10-23
- A Real Product Strategy Helps Your Team Say No, Says Tim Herbig — aakashgupta · 2026-10-23
- IBM CEO's quantified AI stance vs HPE CEO's 'buzzword soup' — analyst picks a side — DavidLinthicum · 2026-10-23
- CMU professor wins NSF-STRIDE AI Efficiency Challenge grant, hiring PhD students and postdocs — sh_reya · 2026-10-23
- Asa Cooper-Stickwell joins METR's embedded monitoring assessment team — idavidrein · 2026-10-23